Literature DB >> 22995025

The 6-minute walk test as a primary endpoint in clinical trials for pulmonary hypertension.

Stuart Rich1.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22995025     DOI： 10.1016/j.jacc.2012.03.080

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  10 in total

1.  Pulmonary Hypertension and Precision Medicine through the "Omics" Looking Glass.

Authors:  Jarrod W Barnes; Raed A Dweik
Journal:  Am J Respir Crit Care Med       Date:  2017-06-15       Impact factor: 21.405

2.  Value of impedance cardiography during 6-minute walk test in pulmonary hypertension.

Authors:  Adriano R Tonelli; Laith Alkukhun; Vineesha Arelli; José Ramos; Jennie Newman; Kevin McCarthy; Bohdan Pichurko; Omar A Minai; Raed A Dweik
Journal:  Clin Transl Sci       Date:  2013-09-06       Impact factor: 4.689

Review 3.  Six-Minute Walk Test: Clinical Role, Technique, Coding, and Reimbursement.

Authors:  Priya Agarwala; Steve H Salzman
Journal:  Chest       Date:  2019-11-02       Impact factor: 9.410

4.  Enhancing Insights into Pulmonary Vascular Disease through a Precision Medicine Approach. A Joint NHLBI-Cardiovascular Medical Research and Education Fund Workshop Report.

Authors:  John H Newman; Stuart Rich; Steven H Abman; John H Alexander; John Barnard; Gerald J Beck; Raymond L Benza; Todd M Bull; Stephen Y Chan; Hyung J Chun; Declan Doogan; Jocelyn Dupuis; Serpil C Erzurum; Robert P Frantz; Mark Geraci; Hunter Gillies; Mark Gladwin; Michael P Gray; Anna R Hemnes; Roy S Herbst; Adrian F Hernandez; Nicholas S Hill; Evelyn M Horn; Kendall Hunter; Zhi-Cheng Jing; Roger Johns; Sanjay Kaul; Steven M Kawut; Tim Lahm; Jane A Leopold; Greg D Lewis; Stephen C Mathai; Vallerie V McLaughlin; Evangelos D Michelakis; Steven D Nathan; William Nichols; Grier Page; Marlene Rabinovitch; Jonathan Rich; Franz Rischard; Sharon Rounds; Sanjiv J Shah; Victor F Tapson; Naomi Lowy; Norman Stockbridge; Gail Weinmann; Lei Xiao
Journal:  Am J Respir Crit Care Med       Date:  2017-06-15       Impact factor: 21.405

Review 5.  Pharmacologic treatments for pulmonary hypertension: exploring pharmacogenomics.

Authors:  Julio D Duarte; Rebekah L Hanson; Roberto F Machado
Journal:  Future Cardiol       Date:  2013-05

6.  Haemodynamically Derived Pulmonary Artery Pulsatility Index Predicts Mortality in Pulmonary Arterial Hypertension.

Authors:  Sula Mazimba; Timothy S Welch; Hunter Mwansa; Khadijah K Breathett; Jamie L W Kennedy; Andrew D Mihalek; William C Harding; Manu M Mysore; David X Zhuo; Kenneth C Bilchick
Journal:  Heart Lung Circ       Date:  2018-04-17       Impact factor: 2.975

7.  Association between six-minute walk distance and long-term outcomes in patients with pulmonary arterial hypertension: Data from the randomized SERAPHIN trial.

Authors:  Rogério Souza; Richard N Channick; Marion Delcroix; Nazzareno Galiè; Hossein-Ardeschir Ghofrani; Pavel Jansa; Franck-Olivier Le Brun; Sanjay Mehta; Loïc Perchenet; Tomás Pulido; B K S Sastry; Olivier Sitbon; Adam Torbicki; Lewis J Rubin; Gérald Simonneau
Journal:  PLoS One       Date:  2018-03-28       Impact factor: 3.240

8.  The incremental shuttle walk test predicts mortality in non-group 1 pulmonary hypertension: results from the ASPIRE Registry.

Authors:  Catherine G Billings; Robert Lewis; Judith A Hurdman; Robin Condliffe; Charlie A Elliot; A A Roger Thompson; Ian A Smith; Matthew Austin; Iain J Armstrong; Neil Hamilton; Athanasios Charalampopoulos; Ian Sabroe; Andrew J Swift; Alexander M Rothman; Jim M Wild; Allan Lawrie; Judith C Waterhouse; David G Kiely
Journal:  Pulm Circ       Date:  2019 Apr-Jun       Impact factor: 3.017

9.  Schistosomiasis-associated pulmonary arterial hypertension: survival in endemic area in Brazil.

Authors:  Carlos G Piscoya Roncal; Adriano A Mendes; Maria T C Muniz; Sheilla A de Oliveira; Leonidas M do Valle Neto; Nathália A de Vasconcellos Piscoya; Gustavo H B Góes; Dario C Sobral Filho; Mardi Gomberg-Maitland
Journal:  Int J Cardiol Heart Vasc       Date:  2019-10-31

10.  The pulmonary hypertension academic research consortium.

Authors:  Stuart Rich
Journal:  Pulm Circ       Date:  2013-01       Impact factor: 3.017
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.